|
1
|
Pieters R and Carroll WL: Biology and
treatment of acute lymphoblastic leukemia. Hematol Oncol Clin North
Am. 24:1–18. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marks DI, Paietta EM, Moorman AV, Richards
SM, Buck G, DeWald G, Ferrando A, Fielding AK, Goldstone AH,
Ketterling RP, et al: T-cell acute lymphoblastic leukemia in
adults: Clinical features, immunophenotype, cytogenetics, and
outcome from the large randomized prospective trial (UKALL XII/ECOG
2993). Blood. 114:5136–5145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gianfelici V, Chiaretti S, Demeyer S, Di
Giacomo F, Messina M, La Starza R, Peragine N, Paoloni F, Geerdens
E, Pierini V, et al: RNA sequencing unravels the genetics of
refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic
and therapeutic implications. Haematologica. 101:941–950. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ko RH, Ji L, Barnette P, Bostrom B,
Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, et
al: Outcome of patients treated for relapsed or refractory acute
lymphoblastic leukemia: A Therapeutic Advances in Childhood
Leukemia Consortium study. J Clin Oncol. 28:648–654. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paszel-Jaworska A, Rubiś B,
Bednarczyk-Cwynar B, Zaprutko L and Rybczyńska M: Proapoptotic
activity and ABCC1-related multidrug resistance reduction ability
of semisynthetic oleanolic acid derivatives DIOXOL and HIMOXOL in
human acute promyelocytic leukemia cells. Chem Biol Interact.
242:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soverini S, De Benedittis C, Papayannidis
C, Paolini S, Venturi C, Iacobucci I, Luppi M, Bresciani P,
Salvucci M, Russo D, et al: Drug resistance and BCR-ABL kinase
domain mutations in Philadelphia chromosome-positive acute
lymphoblastic leukemia from the imatinib to the second-generation
tyrosine kinase inhibitor era: The main changes are in the type of
mutations, but not in the frequency of mutation involvement.
Cancer. 120:1002–1009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kiraz Y, Adan A, Yandim M Kartal and Baran
Y: Major apoptotic mechanisms and genes involved in apoptosis.
Tumour Biol. 37:8471–8486. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fodale V, Pierobon M, Liotta L and
Petricoin E: Mechanism of cell adaptation: When and how do cancer
cells develop chemoresistance? Cancer J. 17:89–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang S, Li G, Ma X, Wang Y, Liu G, Feng
L, Zhao Y, Zhang G, Wu Y, Ye X, et al: Norcantharidin enhances
ABT-737-induced apoptosis in hepatocellular carcinoma cells by
transcriptional repression of Mcl-1. Cell Signal. 24:1803–1809.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li G, Chang H, Zhai YP and Xu W: Targeted
silencing of inhibitors of apoptosis proteins with siRNAs: A
potential anti-cancer strategy for hepatocellular carcinoma. Asian
Pac J Cancer Prev. 14:4943–4952. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karami H, Baradaran B, Esfehani A,
Sakhinia M and Sakhinia E: Down-regulation of Mcl-1 by small
interference RNA induces apoptosis and sensitizes HL-60 leukemia
cells to etoposide. Asian Pac J Cancer Prev. 15:629–635. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
High LM, Szymanska B, Wilczynska-Kalak U,
Barber N, O'Brien R, Khaw SL, Vikstrom IB, Roberts AW and Lock RB:
The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic
machinery in acute lymphoblastic leukemia resulting in synergistic
in vitro and in vivo interactions with established drugs. Mol
Pharmacol. 77:483–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Akagi H, Higuchi H, Sumimoto H, Igarashi
T, Kabashima A, Mizuguchi H, Izumiya M, Sakai G, Adachi M,
Funakoshi S, et al: Suppression of myeloid cell leukemia-1 (Mcl-1)
enhances chemotherapy-associated apoptosis in gastric cancer cells.
Gastric cancer. 16:100–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lisowsky T, Lee JE, Polimeno L,
Francavilla A and Hofhaus G: Mammalian augmenter of liver
regeneration protein is a sulfhydryl oxidase. Dig Liver Dis.
33:173–180. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu HY, Xiang DR, Huang HJ, Li J and Sheng
JF: Expression level of augmenter of liver regeneration in patients
with hepatic failure and hepatocellular carcinoma. Hepatobiliary
Pancreat Dis Int. 9:492–498. 2010.PubMed/NCBI
|
|
17
|
Liao XH, Zhang L, Liu Q, Sun H, Peng CM
and Guo H: Augmenter of liver regeneration protects kidneys from
ischaemia/reperfusion injury in rats. Nephrol Dial Transplant.
25:2921–2929. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Polimeno L, Pesetti B, De Santis F, Resta
L, Rossi R, De Palma A, Girardi B, Amoruso A and Francavilla A:
Decreased expression of the augmenter of liver regeneration results
in increased apoptosis and oxidative damage in human-derived glioma
cells. Cell Death Dis. 3:e2892012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Polimeno L, Pesetti B, Giorgio F, Moretti
B, Resta L, Rossi R, Annoscia E, Patella V, Notarnicola A,
Mallamaci R, et al: Expression and localization of augmenter of
liver regeneration in human muscle tissue. Int J Exp Pathol.
90:423–430. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan R, Zhang L, Xia N, Liu Q, Sun H and
Guo H: Knockdown of augmenter of liver regeneration in HK-2 cells
inhibits inflammation response via the mitogen-activated protein
kinase signaling pathway. Inflamm Res. 64:453–462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang N, Sun H, Shen Y, Li XF, Pan T, Liu
GL and Liu Q: Augmenter of liver regeneration inhibits apoptosis of
activated human peripheral blood lymphocytes in vitro.
Immunopharmacol Immunotoxicol. 35:257–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han LH, Dong LY, Yu H, Sun GY, Wu Y, Gao
J, Thasler W and An W: Deceleration of liver regeneration by
knockdown of augmenter of liver regeneration gene is associated
with impairment of mitochondrial DNA synthesis in mice. Am J
Physiol Gastrointest Liver Physiol. 309:G112–G122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumar S, Wang J, Rani R and Gandhi CR:
Hepatic deficiency of augmenter of liver regeneration exacerbates
alcohol-induced liver injury and promotes fibrosis in mice. PLoS
One. 11:e01478642016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mu M, Zhang Z, Cheng Y, Liu G, Chen X, Wu
X, Zhuang C, Liu B, Kong X and You S: Augmenter of liver
regeneration (ALR) restrains concanavalin A-induced hepatitis in
mice. Int Immunopharmacol. 35:280–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen Y, Liu Q, Sun H, Li X, Wang N and Guo
H: Protective effect of augmenter of liver regeneration on
vincristine-induced cell death in Jurkat T leukemia cells. Int
Immunopharmacol. 17:162–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cao Y, Fu YL, Yu M, Yue PB, Ge CH, Xu WX,
Zhan YQ, Li CY, Li W and Wang XH: Human augmenter of liver
regeneration is important for hepatoma cell viability and
resistance to radiation-induced oxidative stress. Free Radic Biol
Med. 47:1057–1066. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Farooq M, Sheng D, Chandramouli C,
Lan T, Mahajan NK, Kini RM, Hong Y, Lisowsky T and Ge R: Augmenter
of liver regeneration (alr) promotes liver outgrowth during
zebrafish hepatogenesis. PLoS One. 7:e308352012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hagiya M, Francavilla A, Polimeno L, Ihara
I, Sakai H, Seki T, Shimonishi M, Porter KA and Starzl TE: Cloning
and sequence analysis of the rat augmenter of liver regeneration
(ALR) gene: Expression of biologically active recombinant ALR and
demonstration of tissue distribution. Proc Natl Acad Sci USA.
91:pp. 8142–8146. 1994; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Todd LR, Damin MN, Gomathinayagam R, Horn
SR, Means AR and Sankar U: Growth factor erv1-like modulates Drp1
to preserve mitochondrial dynamics and function in mouse embryonic
stem cells. Mol Biol Cell. 21:1225–1236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Polimeno L, Pesetti B, Lisowsky T, Iannone
F, Resta L, Giorgio F, Mallamaci R, Buttiglione M, Santovito D,
Vitiello F, et al: Protective effect of augmenter of liver
regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y
human neuroblastoma cells. Free Radic Res. 43:865–875. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Wei K, Lu C, Li Y, Li M, Xing G, Wei
H, Wang Q, Chen J, Wu C, et al: Identification of hepatopoietin
dimerization, its interacting regions and alternative splicing of
its transcription. Eur J Biochem. 269:3888–3893. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Giorda R, Hagiya M, Seki T, Shimonishi M,
Sakai H, Michaelson J, Francavilla A, Starzl TE and Trucco M:
Analysis of the structure and expression of the augmenter of liver
regeneration (ALR) gene. Mol Med. 2:97–108. 1996.PubMed/NCBI
|
|
33
|
Lisowsky T: ERV1 is involved in the
cell-division cycle and the maintenance of mitochondrial genomes in
Saccharomyces cerevisiae. Curr Genet. 26:15–20. 1994. View Article : Google Scholar : PubMed/NCBI
|
